These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 28675321)
21. Australian community pharmacy services: a survey of what people with chronic conditions and their carers use versus what they consider important. McMillan SS; Kelly F; Sav A; King MA; Whitty JA; Wheeler AJ BMJ Open; 2014 Dec; 4(12):e006587. PubMed ID: 25488098 [TBL] [Abstract][Full Text] [Related]
22. Consumer perceptions of community pharmacy-based promotion of mental health and well-being. Hall B; Kelly F; Wheeler AJ; McMillan SS Health Promot J Austr; 2021 Jan; 32(1):26-31. PubMed ID: 31821666 [TBL] [Abstract][Full Text] [Related]
23. Perceptions of crisis care in populations who self-referred to a telephone-based mental health triage service. Sands N; Elsom S; Keppich-Arnold S; Henderson K; Thomas PA Int J Ment Health Nurs; 2016 Apr; 25(2):136-43. PubMed ID: 26733103 [TBL] [Abstract][Full Text] [Related]
24. Development of a questionnaire to measure consumers' perceptions of service quality in community pharmacies. Mirzaei A; Carter SR; Chen JY; Rittsteuer C; Schneider CR Res Social Adm Pharm; 2019 Apr; 15(4):346-357. PubMed ID: 29903653 [TBL] [Abstract][Full Text] [Related]
25. Low perceived service quality in community pharmacy is associated with poor medication adherence. Carter S; Ng R; El-Den S; Schneider C Patient Educ Couns; 2021 Feb; 104(2):387-394. PubMed ID: 32788130 [TBL] [Abstract][Full Text] [Related]
26. The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial. van der Laan DM; Elders PJ; Boons CC; Bosmans JE; Nijpels G; Hugtenburg JG Trials; 2017 Jan; 18(1):29. PubMed ID: 28103948 [TBL] [Abstract][Full Text] [Related]
27. Consumer satisfaction with opioid treatment services at community pharmacies in Australia. Lea T; Sheridan J; Winstock A Pharm World Sci; 2008 Dec; 30(6):940-6. PubMed ID: 18850299 [TBL] [Abstract][Full Text] [Related]
28. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Armour C; Bosnic-Anticevich S; Brillant M; Burton D; Emmerton L; Krass I; Saini B; Smith L; Stewart K Thorax; 2007 Jun; 62(6):496-502. PubMed ID: 17251316 [TBL] [Abstract][Full Text] [Related]
29. The structural and process aspects of pharmacy quality: older adults' perceptions. Shiyanbola OO; Mott DA; Croes KD Int J Clin Pharm; 2016 Feb; 38(1):96-106. PubMed ID: 26499502 [TBL] [Abstract][Full Text] [Related]
30. Acceptance of a medication refill reminder service in German community pharmacy practice. Breiholz S; -Mammen NG; Krueger K; Schaefer M; Schulz M Pharmazie; 2019 Mar; 74(3):186-190. PubMed ID: 30961687 [TBL] [Abstract][Full Text] [Related]
31. Implementation of medication review with follow-up in a Spanish community pharmacy and its achieved outcomes. Ocampo CC; Garcia-Cardenas V; Martinez-Martinez F; Benrimoj SI; Amariles P; Gastelurrutia MA Int J Clin Pharm; 2015 Oct; 37(5):931-40. PubMed ID: 26040837 [TBL] [Abstract][Full Text] [Related]
32. The UK Pharmacy Care Plan service: Description, recruitment and initial views on a new community pharmacy intervention. Twigg MJ; Wright D; Kirkdale CL; Desborough JA; Thornley T PLoS One; 2017; 12(4):e0174500. PubMed ID: 28369064 [TBL] [Abstract][Full Text] [Related]
33. Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies. Blackburn DF; Evans CD; Eurich DT; Mansell KD; Jorgenson DJ; Taylor JG; Semchuk WM; Shevchuk YM; Remillard AJ; Tran DA; Champagne AP Pharmacotherapy; 2016 Oct; 36(10):1055-1064. PubMed ID: 27581815 [TBL] [Abstract][Full Text] [Related]
34. The Medicines Advice Service Evaluation (MASE): a randomised controlled trial of a pharmacist-led telephone based intervention designed to improve medication adherence. Lyons I; Barber N; Raynor DK; Wei L BMJ Qual Saf; 2016 Oct; 25(10):759-69. PubMed ID: 26755665 [TBL] [Abstract][Full Text] [Related]
35. Exploring the relationship between mental health stigma, knowledge and provision of pharmacy services for consumers with schizophrenia. O'Reilly CL; Bell JS; Kelly PJ; Chen TF Res Social Adm Pharm; 2015; 11(3):e101-9. PubMed ID: 23632161 [TBL] [Abstract][Full Text] [Related]
36. Advancing the use of community pharmacy quality measures: a qualitative study. Shiyanbola OO; Mort JR; Lyons K J Am Pharm Assoc (2003); 2013; 53(4):400-7. PubMed ID: 23892813 [TBL] [Abstract][Full Text] [Related]